par Dramaix Wilmet, Michèle 
;Kornitzer, Marcel ;Thilly, Claude Hector ;Kittel, France ;Graffar, M.
Référence Revue d'épidémiologie et de santé publique, 29, page (289-303)
Publication Publié, 1981
;Kornitzer, Marcel ;Thilly, Claude Hector ;Kittel, France ;Graffar, M.Référence Revue d'épidémiologie et de santé publique, 29, page (289-303)
Publication Publié, 1981
Article révisé par les pairs
| Résumé : | The Belgian Heart Disease Prevention Project is a controlled multifactorial preventive trial. It is basal on the well-documented epidemiologic notion of major coronary risk-factors: hypercholesterolemia, hypertension, smoking and obesity. This Project has been executed in industries, in males aged 40-59 yrs at the base-line screening. It is part of the WHO European Collaborative Trial including the United-Kingdom, Italy, Poland and Spain. This trial should verify a double work-hypothesis: 1 degree it is possible to modify significantly the coronary risk profile in middle-aged males through a comprehensive intervention program, 2 degrees this modification should, in turn, significantly reduce total mortality as compared to a control group. The authors discuss the pros and cons of a preventive trial in industry and review the numerous problems raised by the difficulties in modifying well-established life-styles as well as those related to the follow-up morbidity and mortality. Final screening took place in 1979-80 and results regarding incidence should be available by 1981. |
